scispace - formally typeset
C

Cinthia Farina

Researcher at Vita-Salute San Raffaele University

Publications -  70
Citations -  6451

Cinthia Farina is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Experimental autoimmune encephalomyelitis & Multiple sclerosis. The author has an hindex of 29, co-authored 67 publications receiving 5129 citations. Previous affiliations of Cinthia Farina include Max Planck Society.

Papers
More filters
Journal ArticleDOI

Astrocytes are active players in cerebral innate immunity

TL;DR: Evidence is emerging that the most abundant glial cell population of the CNS, the astrocyte, participates in the local innate immune response triggered by a variety of insults.
Journal ArticleDOI

Reactive astrocyte nomenclature, definitions, and future directions

Carole Escartin, +88 more
- 15 Feb 2021 - 
TL;DR: In this article, the authors point out the shortcomings of binary divisions of reactive astrocytes into good-vs-bad, neurotoxic vs-neuroprotective or A1-vs.A2.
Journal ArticleDOI

Astrocytes: Key Regulators of Neuroinflammation.

TL;DR: In vivo studies on astrocyte signaling in neuroinflammatory models focusing on evidences obtained from the analysis of transgenic mice are re-visited, clarifying precise signaling steps, highlighting the crosstalk among pathways and identifies shared effector mechanisms in neuroinflammation.
Journal ArticleDOI

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

TL;DR: The strong linkage of CXCL13 to immune cells and immunoglobulin levels in CSF suggests that this is one of the factors that attract and maintain B and T cells in inflamed CNS lesions.
Journal ArticleDOI

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

TL;DR: Interestingly, although there was no proliferative cross-reaction, about 10% of the COP-reactive TCL responded to MBP by secretion of small amounts of IL-4 or IFN-gamma, depending on the cytokine profile of the TCL.